ESR1 and triple-negative breast carcinoma: BC could be clustered into molecular subtypes, including luminal, human epidermal growth factor receptor 2-positive (HER2+) and triple-negative breast cancer (TNBC) tumors based on the expression of the estrogen receptor (ER), progesterone receptor (PR), and the overexpression of the HER2.